Fritextsökning
Innehållstyper
-
Medicon Village breakfast seminar: ISO 10993-1 in practice
Don't miss our breakfast seminar at Medicon Village on May 28th: ISO 10993-1 in practice - connecting biological evaluation to your technical documentation.
-
GU Ventures AB
-
Drug approved for condition causing extreme hunger
The U.S. Food and Drug Administration (FDA) has for the first time approved a drug for acquired hypothalamic obesity, a condition marked by rapid weight gain dr...
-
New global standard for clinical evaluation is on the horizon: ISO/DIS 18969
A new global standard for clinical evaluation is on the horizon: ISO/DIS 18969. The core message is straightforward: clinical evaluations should be seen as a pr...
-
Vaccinforskning om hantavirus lyfter Moderna – ”Tidigt skede”
Efter utbrottet av hantavirus ombord på kryssningsfartyget Hondius har uppmärksamheten riktats mot vaccin- och biotechsektorn. Flera bolag med koppling till inf...
-
Disappointment for Diamyd in Phase III – the share price plunges
Diamyd Medical’s share was sharply down on Monday following negative Phase III results. “This outcome is highly unexpected,” said the company’s CEO, Ulf Hannelius.
-
New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows
Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.
-
Sprint Bioscience builds the molecules that will become new medicines
In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinic...
-
Custom regulatory and clinical strategy workshops
A strong regulatory and clinical strategy early on can save months of rework later.
-
Any Image Size, Many Formats, AI-Powered
ZEISS arivis optimizes local server or cloud computation resources.
-
QAdvis is now Aurevia
Two years ago, QAdvis became part of something bigger. At first, the change was mostly visible on paper — a new owner and later a new name: Aurevia. But this wa...
-
New version of ISO 10993-1: the core standard for the biological evaluation of medical devices
ISO 10993-1, the core standard for the biological evaluation of medical devices, has been under revision over the past few years. A Final Draft International St...
-
Internal audits based on ISO 13485 for medtech organizations
Are you ready to turn your internal audits into real improvements? Internal auditing isn’t just about compliance—it’s a strategic tool for driving development a...
-
Nordic collaboration delivering the next leap in spatial biology
Spatial biology is reshaping how researchers understand complex tissue environments, from tumour–immune interactions to treatment response. A major barrier has ...
-
Shaping the Future of Metrology – Live in Your Region
Insights into our event series.
-
“Ozempic babies” – myth or reality?
Have weight-loss drugs such as Ozempic led to a rise in unplanned pregnancies? Life Science Sweden takes a closer look.
-
Samuel Lagercrantz: ”Obesity, blockbusters and Swedish biotech”
The development of technologies to bypass the blood-brain barrier is particularly exciting right now, as it holds the potential to unlock new treatments for a r...
-
JMP Statistical Discovery
-
Measuring small and sensitive parts with higher precision and speed
New ZEISS Metrology Expert Tip is available exclusively in the ZEISS Metrology Shop.
-
Networking event in Denmark: Sponsor Oversight in Clinical Trials
We are excited to invite clinical trial professionals to a networking event to connect and discuss best practices, challenges and adaptive strategies in documen...
-
ISO 13485 Standard Internal Auditing Course
Do you work with medical devices and quality management? Strengthen your expertise with our ISO 13485 Standard Internal Auditing Training — designed to give you...
-
National cord blood bank resumes collection
The collection of umbilical cord blood is now resuming during planned caesarean sections at Östra Hospital in Gothenburg. The blood remaining in the placenta an...
-
How MoniDose strengthened their regulatory confidence—fast
When MoniDose began their startup journey, regulations were their biggest challenge. Missing early design inputs tied to standards could have meant costly redesigns later.
-
First injectable cancer medicine for home use receives green light
Johnson & Johnson has announced that its blockbuster cancer medicine Darzalex (daratumumab) is set to become the first injectable cancer treatment in Europe sui...